Ciclesonide: a safe and effective inhaled corticosteroid for the treatment of asthma

References

• FuhlbriggeALAdamsRJGuillbertTWThe burden of asthma in the United StatesAm J Repir Crit Care Med200216610441049
   PubMed Web of Science ®Google Scholar
• KivitySShochatZBresslerRWienerMLermanYThe characteristics of bronchial asthma among a young adult populationChest199510824277606964
   PubMed Web of Science ®Google Scholar
• AkinbamiLThe state of childhood asthma, United States 1980–2005 Advance data from vital and health statistics: no 381Hyattsville, MDNational Center for Health Statistics2006
   Google Scholar
• ManninoDMHomaDMAkinbamiLJSurveillance for asthma – United States 1980–1999MMWR Surveill Summ2002329511113
   PubMed Web of Science ®Google Scholar
• National Asthma Education and Prevention ProgramNAEPP Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma – Full Report 2007Bethesda, MDNational Institutes of Health, National Heart, Lung and Blood Institute82007
   Google Scholar
• Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA)2007 Available from: http://www.ginasthma.org.
   Google Scholar
• PedersenSHansenORBudesonide treatment of moderate and severe asthma in children: a dose-response studyJ Allergy Clin Immunol1995951pt 129337822661
   PubMed Web of Science ®Google Scholar
• ShapiroGMendelsonLKraemerMCruz-RiveraMWalton-BowenKSmithJAEfficacy and safety of budesonide inhalation suspension in young children with inhaled steroid-dependent, persistent asthmaJ Allergy Clin Immunol19981027897969819296
   PubMed Web of Science ®Google Scholar
• SkonerDPBalancing safety and efficacy in pediatric asthma managementPediatrics20021092 suppl38139211826254
   PubMed Web of Science ®Google Scholar
• BeckerABKuznetsovaOVermeulenJPediatric Montelukast Linear Growth Study GroupLinear growth in prepubertal asthmatic children treated with montelukast, beclomethasone, or placebo: a 56-week randomized double-blind studyAnn Allergy Asthma Immunol200696680080716802767
   PubMed Web of Science ®Google Scholar
• SimonsFEA comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study GroupN Engl J Med199733723165916659385125
   PubMed Web of Science ®Google Scholar
• HananiaNAChapmanKRSturtridgeWCDose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroidsJ Allergy Clin Immunol1995965Pt 15715797499672
   PubMed Web of Science ®Google Scholar
• IsraelEBanerjeeTRFitzmauriceGMKotlovTVLaHiveKLeBoffMSEffects of inhaled glucocorticoids on bone density in premenopausal womenN Engl J Med20013451394194711575285
   PubMed Web of Science ®Google Scholar
• ZollnerEWHypothalamic-pituitary-adrenal axis suppression in asthmatic children on inhaled corticosteroids (Part 2) – the risk as determined by gold standard adrenal function tests: a systematic reviewPediatr Allergy Immunol200718646947417680905
   PubMed Web of Science ®Google Scholar
• ChrousosGPGhalyLSheddenAIezzoniDGHarrisAGEffects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjectsChest20051281707716002918
   PubMed Web of Science ®Google Scholar
• RachelefskyGSLiaoYFaruqiRImpact of inhaled corticosteroid-induced oropharyngeal adverse events: results from a meta-analysisAnn Allergy Asthma Immunol200798322523817378253
   PubMed Web of Science ®Google Scholar
• FukushimaCMatsuseHSaekiSSalivary IgA and oral candidiasis in asthmatic patients treated with inhaled corticosteroidJ Asthma200542760160416169797
   PubMed Web of Science ®Google Scholar
• StoeckMRiedelRHochhausGIn vitro and in vivo anti-inflammatory activity of the new glucocorticoid ciclesonideJ Pharmacol Exp Ther200430924925814718604
   PubMed Web of Science ®Google Scholar
• ChristiePCiclesonide: A novel inhaled corticosteroid for asthmaDrugs Today (Barc)200440756957615510231
   PubMed Web of Science ®Google Scholar
• NaveRDrollmanAMeyerWZechKIn vivo epimeric stability of ciclesonideAm J Respir Crit Care Med2003167 Abstract A1485.
   Google Scholar
• NaveRGunawardenaKAZechKBethkeTDPharmacokinetic disposition of inhaled ciclesonide and its metabolite desisobutyryl-ciclesonide in healthy subjects and patients with asthma are similarInt J Clin Pharm Ther200644117
   Web of Science ®Google Scholar
• DrollmannANaveRSteinijansVWBaumgartnerEBethkeTDEquivalent pharmacokinetics of the active metabolite of ciclesonide with and without use of the AeroChamber Plus spacer for inhalationClin Pharmacokinet20064572973616802853
   PubMed Web of Science ®Google Scholar
• NaveRFisherRZechKIn vitro metabolism of ciclesonide in human lung and liver precision-cut tissue slicesBiopharm Drug Dispos20062719720716566061
   PubMed Web of Science ®Google Scholar
• NaveRFischerRMcCrackenNIn vitro metabolism of beclomethasone dipropionate, budesonide, ciclesonide, and fluticasone propionate in human lung precision-cut tissue slicesRespir Res200786517883839
   PubMed Web of Science ®Google Scholar
• NaveRBethkeTDvan MarleSPZechKPharmacokinetics of [14C]-Ciclesonide after oral administration to healthy subjectsClin Pharmacokinet200443747948615139796
   PubMed Web of Science ®Google Scholar
• DrollmanAHasselquistBEBoudreauRJCiclesonide shows high lung deposition in 2D and 3D-imagingAm J Respr Crit Care Med2002165 Abstract A40.
   Google Scholar
• RohtagiSAryaVZechKPopulation pharmacokinetics and pharmacodynamics of ciclesonideJ Clin Pharmacol20034336537812723457
   PubMed Web of Science ®Google Scholar
• LeachCBethkeTBoudreauR2-D and 3-D imaging show ciclesonide has high lung deposition and peripheral distribution: a nonrandomized study in healthy volunteersJ Aerosol Med20061911712616796536
   PubMedGoogle Scholar
• NaveRSatoHNonakaTMochidukiTTakahamaSKondoSUptake, retention and metabolism of ciclesonide in human alveolar epithelial cellsEur Respir J200526suppl 49255s
   Google Scholar
• ReynoldsRAScottLJCiclesonideDrugs200464551151914977388
   PubMed Web of Science ®Google Scholar
• DahlRNielsenLPChristensenMBEngelstätterRCiclesonide – an inhaled corticosteroid prodrug – inhibits allergen induced early and late phase reactionsEur Respir J199812suppl 2826s Abstract P0475.
   Google Scholar
• NonakaTSugiyamaHTanedaMEffect of a novel inhaled glucocorticoid, ciclesonide, on an allergen-induced asthmatic response in rats and its prolonged anti-inflammatory activity in vitroEur Respir J200220suppl 38 Abstract P652.
   Google Scholar
• WilsonAMDuongMPrattBDolovichMO’ByrnePMAnti-inflammatory effects of once daily low dose inhaled ciclesonide in mild to moderate asthmatic patientsAllergy20066153754216629781
   PubMed Web of Science ®Google Scholar
• BatemanEKarpelJCasaleTWenzelSBanerjiDCiclesonide reduces the need for oral steroid use in adult patients with severe, persistent asthmaChest20061291176118716685007
   PubMed Web of Science ®Google Scholar
• O’ConnorBJKilfeatherSCheungDTreatment of moderate to severe asthma with ciclesonide: a long-term investigation over 52 weeksEur Respir J200220suppl 38 Abstract 2579.
   Google Scholar
• LangdonCGAdlerMMehraSAlexanderMDrollmanAOnce-daily ciclesonide is safe and effective in patients with persistent asthmaRespir Med2005991275128516024244
   PubMed Web of Science ®Google Scholar
• ChapmanKRPatelPD’UrzoADMaintenance of asthma control by once-daily ciclesonide in adults with persistent asthmaAllergy20056033033715679718
   PubMed Web of Science ®Google Scholar
• GelfandEWGeorgitisJWNoonanMRuffMEOnce-daily ciclesonide in children: efficacy and safety in asthmaJ Pediatr200614837738316615971
   PubMed Web of Science ®Google Scholar
• PostmaDSSevetteCMartinatYSchlösserNAumannJKaféHTreatment of asthma by the inhaled corticosteroid ciclesonide given either in the morning or eveningEur Respir J2001171083108811491148
   PubMed Web of Science ®Google Scholar
• KnoxALanganJMartinotJBGrussCHäfnerDComparison of a step-down dose of once-daily ciclesonide with a continued dose of twice-daily fluticasone propionate in maintaining control of asthmaCurr Med Res Opin200723102387239417714607
   PubMed Web of Science ®Google Scholar
• LeeDKHaggartKCurrieGPBatesCELipworthBJEffects of hydroflouroalkane formulations of ciclesonide 400 μg once daily vs fluticasone 250 μg twice daily on methacholine hyper-responsiveness in mild-to-moderate persistent asthmaBr J Clin Pharm20045812633
   PubMed Web of Science ®Google Scholar
• BuhlRVinklerIMagyarPComparable efficacy of ciclesonide once daily versus fluticasone propionate twice daily in asthmaPulm Pharmacol Ther200619640441216310388
   PubMed Web of Science ®Google Scholar
• UkenaDBibergerCSteinijansVCiclesonide is more effective than budesonide in the treatment of persistent asthmaPulm Pharmacol Ther200720556257016962345
   PubMed Web of Science ®Google Scholar
• NiphadkarPJagannathKJoshiJMComparison of the efficacy of ciclesonide 160 μg QD and budesonide 200 μg BID in adults with persistent asthma: A phase III, randomized, double-dummy, open-label studyClin Ther200527111752176316368446
   PubMed Web of Science ®Google Scholar
• BouletLPDrollmanAMagyarPComparative efficacy of once-daily ciclesonide and budesonide in the treatment of persistent asthmaRespir Med200610078579416427266
   PubMed Web of Science ®Google Scholar
• HanselTTBenezetOKaféHA multinational, 12-week, randomized study comparing the efficacy and tolerability of ciclesonide and budesonide in patients with asthmaClin Ther200628690692016860173
   PubMed Web of Science ®Google Scholar
• von BergAEngelstätterRMinicPComparison of the efficacy and safety of ciclesonide 160 μg once daily vs budesonide 400 μg once daily in children with asthmaPediatr Allergy Immunol20071839140017617808
   PubMed Web of Science ®Google Scholar
• VermeulenJHGyurkovitsKRauerHEngelstätterRRandomized comparison of the efficacy and safety of ciclesonide and budesonide in adolescents with severe asthmaRespir Med2007101102182219117614270
   PubMed Web of Science ®Google Scholar
• BouletLPBatemanEDVovesRMüllerTWolfSEngelstätterRA randomized study comparing ciclesonide and fluticasone propionate in patients with moderate persistent asthmaRespir Med200710181677168617448650
   PubMed Web of Science ®Google Scholar
• BatemanEDLinnhofAEHomikLFreudensprungUSmauLEngelstätterRComparison of twice-daily inhaled ciclesonide and fluticasone propionate in patients with moderate-to-severe persistent asthmaPulm Pharmacol Ther200821226427517604664
   PubMed Web of Science ®Google Scholar
• PedersenSGarcia GarciaMLManjraAITheronIEngelstätterRA comparative study of inhaled ciclesonide 160 μg/day and fluticasone propionate 176 μg/day in children with asthmaPediatr Pulmonol2006411095496116868976
   PubMed Web of Science ®Google Scholar
• RichterKKanniessFBibergerCNaveRMagnussenHComparison of the oropharyngeal deposition of inhaled ciclesonide and fluticasone propionate in patients with asthmaJ Clin Pharmacol20054514615215647406
   PubMed Web of Science ®Google Scholar
• NaveRZechKBethkeTDLower oropharyngeal deposition of inhaled ciclesonide via hydroflouroalkane metered-dose inhaler compared with budesonide via chlorofluorocarbon metered-dose inhaler in healthy subjectsEur J Clin Pharmacol20056120320815824911
   PubMed Web of Science ®Google Scholar
• PearlmanDSBergerWEKerwinELaForceCKunduSBanerjiDOnce-daily ciclesonide improves lung function and is well tolerated by patients with mild-to-moderate persistent asthmaJ Allergy Clin Immunol20051161206121216337447
   PubMed Web of Science ®Google Scholar
• AgertoftLPedersenSShort-term lower-leg growth rate and urine cortisol excretion in children treated with ciclesonideJ Allergy Clin Immunol200511594094515867849
   PubMed Web of Science ®Google Scholar
• SzeflerSRohatagiSWilliamsJLloydMKunduSBanerjiDCiclesonide, a novel inhaled steroid, does not affect hypthalamic-pituitary-adrenal axis function in patients with moderate-to-severe persistent asthmaChest20051281104111416162694
   PubMed Web of Science ®Google Scholar
• LipworthBJKalinerMALaForceCFBakerJWKaiserHBAminDEffect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis function in adults with mild-to-moderate persistent asthmaAnn Allergy Asthma Immunol20059446547215875528
   PubMed Web of Science ®Google Scholar
• DeromEVan De VeldeVMarissensSEngelstätterRVinckenWPauwelsREffects of inhaled ciclesonide and fluticasone propionate on cortisol secretion and airway responsiveness to adenosine 5’monophosphate in asthmatic patientsPulm Pharmacol Ther200518532833615939311
   PubMed Web of Science ®Google Scholar
• SkonerDPMasperoJBanerjiDthe Ciclesonide Pediatric Growth Study GroupAssessment of the long-term safety of inhaled ciclesonide on growth in children with asthmaPediatrics20081211e11418070931
   PubMed Web of Science ®Google Scholar
• AgertoftLPedersenSEffect of long-term treatment with inhaled budesonide on adult height in children with asthmaN Engl J Med2000343151064106911027740
   PubMed Web of Science ®Google Scholar
• RohatagiSLuoYShenLGuoZSchemmCHuangYProtein binding and its potential for eliciting minimal systemic side effects with a novel inhaled corticosteroid, ciclesonideAm J Ther200512320120915891262
   PubMedGoogle Scholar
• NaveRMeyerWFuhstRZechKFormation of fatty acid conjugates of ciclesonide active metabolite in the rat lung after 4-week inhalation of ciclesonidePulm Pharmacol Ther20051839039616179214
   PubMed Web of Science ®Google Scholar